Cartesian Therapeutics, Inc. — Director's Dealing 2021

Apr 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2021-03-30

Reporting Person: BARABE TIMOTHY C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-30	Stock Option (Right to Buy)	$4.01	A	40000	Acquired	2031-03-29	Common Stock (40000.0)	Direct

Footnotes

F1: This option vests in full on March 30, 2022.